These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
89 related articles for article (PubMed ID: 12033514)
1. In vitro susceptibility of four serotypes of enterohaemorrhagic Escherichia coli to antimicrobial agents. Oie S; Kawakami M; Kamiya A; Tomita M Biol Pharm Bull; 2002 May; 25(5):671-3. PubMed ID: 12033514 [TBL] [Abstract][Full Text] [Related]
2. In vitro bactericidal activity of antimicrobial agents against enterohaemorrhagic Escherichia coli. Oie S; Ishitobi J; Sawa A; Tomita M; Kamiya A J Antimicrob Chemother; 2004 Nov; 54(5):897-903. PubMed ID: 15472004 [TBL] [Abstract][Full Text] [Related]
3. In vitro susceptibility of Escherichia coli O157 to several antimicrobial agents. Oie S; Kamiya A; Tomita M; Matsusaki S; Katayama A; Iwasaki A Biol Pharm Bull; 1997 May; 20(5):584-5. PubMed ID: 9178946 [TBL] [Abstract][Full Text] [Related]
4. Antimicrobial susceptibility of Escherichia coli O157 and other enterohaemorrhagic Escherichia coli isolated in Italy. Farina C; Goglio A; Conedera G; Minelli F; Caprioli A Eur J Clin Microbiol Infect Dis; 1996 Apr; 15(4):351-3. PubMed ID: 8781893 [No Abstract] [Full Text] [Related]
5. Antimicrobial resistance of Shiga toxin (verotoxin)-producing Escherichia coli O157:H7 and non-O157 strains isolated from humans, cattle, sheep and food in Spain. Mora A; Blanco JE; Blanco M; Alonso MP; Dhabi G; Echeita A; González EA; Bernárdez MI; Blanco J Res Microbiol; 2005 Aug; 156(7):793-806. PubMed ID: 15921895 [TBL] [Abstract][Full Text] [Related]
6. Effect of antimicrobial agents, especially fosfomycin, on the production and release of Vero toxin by enterohaemorrhagic Escherichia coli O157:H7. Yoh M; Frimpong EK; Honda T FEMS Immunol Med Microbiol; 1997 Sep; 19(1):57-64. PubMed ID: 9322069 [TBL] [Abstract][Full Text] [Related]
7. Effect of nanoliposomes containing Zataria multiflora Boiss. essential oil on gene expression of Shiga toxin 2 in Escherichia coli O157:H7. Khatibi SA; Misaghi A; Moosavy MH; Akhondzadeh Basti A; Mohamadian S; Khanjari A J Appl Microbiol; 2018 Feb; 124(2):389-397. PubMed ID: 29152837 [TBL] [Abstract][Full Text] [Related]
9. The stimulating effect of fosfomycin, an antibiotic in common use in Japan, on the production/release of verotoxin-1 from enterohaemorrhagic Escherichia coli O157:H7 in vitro. Yoh M; Honda T Epidemiol Infect; 1997 Aug; 119(1):101-3. PubMed ID: 9287950 [TBL] [Abstract][Full Text] [Related]
10. [The drug susceptibility pattern of the presumed etiologic agents of infectious enteritis including verotoxin-producing Escherichia coli O-157]. Deguchi K; Suzuki Y; Ishihara R; Ishii Y; Nakazawa A Jpn J Antibiot; 1997 Oct; 50(10):829-43. PubMed ID: 9412873 [TBL] [Abstract][Full Text] [Related]
11. The antimicrobial activity of mecillinam, nitrofurantoin, temocillin and fosfomycin and comparative analysis of resistance patterns in a nationwide collection of ESBL-producing Escherichia coli in Norway 2010-2011. Zykov IN; Sundsfjord A; Småbrekke L; Samuelsen Ø Infect Dis (Lond); 2016 Feb; 48(2):99-107. PubMed ID: 26414659 [TBL] [Abstract][Full Text] [Related]
12. [Activity of fosfomycin against Escherichia coli O157:H7--morphological changes and production of Shiga toxins]. Takata T; Tabata M; Tsuruoka T; Watabe H Jpn J Antibiot; 2003 Dec; 56(6):691-6. PubMed ID: 15007877 [TBL] [Abstract][Full Text] [Related]
13. [Status of emerging drug resistance in Shiga toxin-producing Escherichia coli in Japan during 1996: a minireview]. Yamamoto T; Wakisaka N Nihon Rinsho; 1998 Oct; 56(10):2718-29. PubMed ID: 9796342 [TBL] [Abstract][Full Text] [Related]
14. [In vitro antibacterial activity of faropenem, a novel oral penem antibiotic, against enterohemorrhagic Escherichia coli O157 strains]. Nasu T; Okamoto K; Nakanishi T; Nishino T Jpn J Antibiot; 1999 Aug; 52(8):541-53. PubMed ID: 10587879 [TBL] [Abstract][Full Text] [Related]
15. [Fosfomycin susceptibility of urinary Escherichia coli isolates producing extended-spectrum beta-lactamase according to CLSI and EUCAST recommendations]. Cağan Aktaş S; Gençer S; Batırel A; Hacıseyitoğlu D; Ozer S Mikrobiyol Bul; 2014 Oct; 48(4):545-55. PubMed ID: 25492650 [TBL] [Abstract][Full Text] [Related]
16. Medium compositions and culture conditions for the assay of fosfomycin susceptibility by Etest. Horii T; Kimura T; Odagiri T; Shibayama K; Ohta M J Infect Chemother; 2000 Mar; 6(1):30-4. PubMed ID: 11810528 [TBL] [Abstract][Full Text] [Related]
17. Antibiotic susceptibility of enterohemorrhagic Escherichia coli O157:H7 isolated from an outbreak in Japan in 1996. Tsuboi I; Ida H; Yoshikawa E; Hiyoshi S; Yamaji E; Nakayama I; Nonomiya T; Shigenobu F; Shimizu M; O'Hara K; Sawai T; Mizuoka K Antimicrob Agents Chemother; 1998 Feb; 42(2):431-2. PubMed ID: 9527800 [TBL] [Abstract][Full Text] [Related]
18. Serotype, Shiga toxin (Stx) type, and antimicrobial resistance of Stx-producing Escherichia coli isolated from humans in Shizuoka Prefecture, Japan (2003-2007). Hiroi M; Takahashi N; Harada T; Kawamori F; Iida N; Kanda T; Sugiyama K; Ohashi N; Hara-Kudo Y; Masuda T Jpn J Infect Dis; 2012; 65(3):198-202. PubMed ID: 22627299 [TBL] [Abstract][Full Text] [Related]
19. Inhibition of verocytotoxigenic Escherichia coli by antimicrobial peptides caseicin A and B and the factors affecting their antimicrobial activities. McDonnell MJ; Rivas L; Burgess CM; Fanning S; Duffy G Int J Food Microbiol; 2012 Feb; 153(3):260-8. PubMed ID: 22177226 [TBL] [Abstract][Full Text] [Related]